Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Gordon Dewald

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

DNA Probes

Anatomy

Occupations

Cytogenetics

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
25
Tefferi, Ayalew
18
Hanson, Curtis
18
Paternoster, Sarah
17
Jalal, Syed
17
Kay, Neil
12
Jelinek, Diane
11
Greipp, Philip
11
Call, Timothy
11
Fink, Stephanie
11
Shanafelt, Tait
11
Smoley, Stephanie
10
Ketterling, Rhett
10
Tschumper, Renee
9
Zent, Clive
9
Jenkins, Robert

Sign-in to see all Coauthors

Publications

TOP 3
Dewald Gordon W; Smyrk Thomas C; Thorland Erik C; McWilliams Robert R; Van Dyke Daniel L; Keefe Jeannette G; Belongie Kimberly J; Smoley Stephanie A; Knutson Darlene L; Fink Stephanie R; Wiktor Anne E; Petersen Gloria M
Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.
Nowakowski Grzegorz S; Hoyer James D; Shanafelt Tait D; Zent Clive S; Call Timothy G; Bone Nancy D; Laplant Betsy; Dewald Gordon W; Tschumper Renee C; Jelinek Diane F; Witzig Thomas E; Kay Neil E
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.
Santana-Davila Rafael; Tefferi Ayalew; Holtan Shernan G; Ketterling Rhett P; Dewald Gordon W; Knudson Ryan A; Steensma David P; Chen Dong; Hoyer James D; Hanson Curtis A
Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gordon Dewald (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Dewald Gordon W; Smyrk Thomas C; Thorland Erik C; McWilliams Robert R; Van Dyke Daniel L; Keefe Jeannette G; Belongie Kimberly J; Smoley Stephanie A; Knutson Darlene L; Fink Stephanie R; Wiktor Anne E; Petersen Gloria M
Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.
Mayo Clinic proceedings. Mayo Clinic 2009;84(9):801-10.
2009: Nowakowski Grzegorz S; Hoyer James D; Shanafelt Tait D; Zent Clive S; Call Timothy G; Bone Nancy D; Laplant Betsy; Dewald Gordon W; Tschumper Renee C; Jelinek Diane F; Witzig Thomas E; Kay Neil E
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1844-9.
2008: Santana-Davila Rafael; Tefferi Ayalew; Holtan Shernan G; Ketterling Rhett P; Dewald Gordon W; Knudson Ryan A; Steensma David P; Chen Dong; Hoyer James D; Hanson Curtis A
Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.
Leukemia research 2008;32(12):1927-30.
2008: Holtan Shernan G; Santana-Davila Rafael; Dewald Gordon W; Khetterling Rhett P; Knudson Ryan A; Hoyer James D; Chen Dong; Hanson Curtis A; Porrata Luis; Tefferi Ayalew; Steensma David P
Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
American journal of hematology 2008;83(9):708-13.
2008: Shanafelt Tait D; Geyer Susan M; Bone Nancy D; Tschumper Renee C; Witzig Tom E; Nowakowski Greg S; Zent Clive S; Call Tim G; Laplant Betsy; Dewald Gordon W; Jelinek Diane F; Kay Neil E
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
British journal of haematology 2008;140(5):537-46.
2008: Santana-Davila Rafael; Holtan Shernan G; Dewald Gordon W; Ketterling Rhett P; Knudson Ryan A; Hanson Curtis A; Steensma David P; Tefferi Ayalew
Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.
Leukemia research 2008;32(3):407-11.
2008: Tschumper Renee C; Geyer Susan M; Campbell Megan E; Kay Neil E; Shanafelt Tait D; Zent Clive S; Nowakowski Grzegorz S; Call Timothy G; Dewald Gordon W; Jelinek Diane F
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.
The Journal of clinical investigation 2008;118(1):306-15.
2007: Browning Rebekah L; Geyer Susan M; Johnson Amy J; Jelinek Diane F; Tschumper Renee C; Call Timothy G; Shanafelt Tait D; Zent Clive S; Bone Nancy D; Dewald Gordon W; Lin Thomas S; Heerema Nyla A; Grever Michael R; Kay Neil E; Byrd John C; Lucas David M
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia.
Leukemia research 2007;31(12):1737-40.
2007: Landstrom Andrew P; Knudson Ryan A; Dewald Gordon W; Ketterling Rhett P; Tefferi Ayalew
Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: clinical correlates and effect on imatinib mesylate treatment outcome.
Leukemia & lymphoma 2007;48(11):2137-40.
2007: Zou Ying S; Fink Stephanie R; Stockero Kimberly J; Paternoster Sarah F; Smoley Stephanie A; Tun Han W; Reeder Craig B; Tefferi Ayalew; Dewald Gordon W
Efficacy of conventional cytogenetics and FISH for EGR1 to detect deletion 5q in hematological disorders and to assess response to treatment with Lenalidomide.
Leukemia research 2007;31(9):1185-9.
2007: Wolff Daynna J; Bagg Adam; Cooley Linda D; Dewald Gordon W; Hirsch Betsy A; Jacky Peter B; Rao Kathleen W; Rao P Nagesh;
Guidance for fluorescence in situ hybridization testing in hematologic disorders.
The Journal of molecular diagnostics : JMD 2007;9(2):134-43.
2007: Moorman Anthony V; Harrison Christine J; Buck Georgina A N; Richards Sue M; Secker-Walker Lorna M; Martineau Mary; Vance Gail H; Cherry Athena M; Higgins Rodney R; Fielding Adele K; Foroni Letizia; Paietta Elisabeth; Tallman Martin S; Litzow Mark R; Wiernik Peter H; Rowe Jacob M; Goldstone Anthony H; Dewald Gordon W;
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
Blood 2007;109(8):3189-97.
2007: Smoley Stephanie A; Fink Stephanie R; Paternoster Sarah F; Stockero Kimberly J; Nguyen Lai P; Nguyen Phuong L; Hanson Curtis A; Dewald Gordon W
Frequency, hematopathology, and detection of a new isodicentric variant of deletion 20q.
Cancer genetics and cytogenetics 2007;173(2):144-9.
2007: Grever Michael R; Lucas David M; Dewald Gordon W; Neuberg Donna S; Reed John C; Kitada Shinichi; Flinn Ian W; Tallman Martin S; Appelbaum Frederick R; Larson Richard A; Paietta Elisabeth; Jelinek Diane F; Gribben John G; Byrd John C
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(7):799-804.
2007: Kay Neil E; Geyer Susan M; Call Timothy G; Shanafelt Tait D; Zent Clive S; Jelinek Diane F; Tschumper Renee; Bone Nancy D; Dewald Gordon W; Lin Thomas S; Heerema Nyla A; Smith Lisa; Grever Michael R; Byrd John C
Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia.
Blood 2007;109(2):405-11.
2006: Remstein Ellen D; Dogan Ahmet; Einerson Richard R; Paternoster Sarah F; Fink Stephanie R; Law Mark; Dewald Gordon W; Kurtin Paul J
The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
The American journal of surgical pathology 2006;30(12):1546-53.
2006: Shanafelt Tait D; Witzig Thomas E; Fink Stephanie R; Jenkins Robert B; Paternoster Sarah F; Smoley Stephanie A; Stockero Kimberly J; Nast Danielle M; Flynn Heather C; Tschumper Renee C; Geyer Susan; Zent Clive S; Call Tim G; Jelinek Diane F; Kay Neil E; Dewald Gordon W
Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4634-41.
2006: Litzow Mark R; Lee Sandra; Bennett John M; Dewald Gordon W; Gallagher Robert E; Jain Vibha; Paietta Elisabeth M; Racevskis Janis; Rousey Steven R; Mazza Joseph J; Tallman Martin S
A phase II trial of arsenic trioxide for relapsed and refractory acute lymphoblastic leukemia.
Haematologica 2006;91(8):1105-8.
2006: Pardanani A; Ketterling R P; Li C-Y; Patnaik M M; Wolanskyj A P; Elliott M A; Camoriano J K; Butterfield J H; Dewald G W; Tefferi A
FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature.
Leukemia research 2006;30(8):965-70.
2006: Brothman Arthur R; Schneider Nancy R; Saikevych Irene; Cooley Linda D; Butler Merlin G; Patil Shivanand; Mascarello James T; Rao Kathleen W; Dewald Gordon W; Park Jonathan P; Persons Diane L; Wolff Daynna J; Vance Gail H;
Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for years.
Archives of pathology & laboratory medicine 2006;130(7):947-9.
2006: Shanafelt Tait D; Jelinek Diane; Tschumper Renee; Schwager Susan; Nowakowski Grzegorz; DeWald Gordon W; Kay Neil E
Cytogenetic abnormalities can change during the course of the disease process in chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3218-9; author reply 3219-20.
2006: Fink Stephanie R; Smoley Stephanie A; Stockero Kimberly J; Paternoster Sarah F; Thorland Erik C; Van Dyke Daniel L; Shanafelt Tait D; Zent Clive S; Call Timothy G; Kay Neil E; Dewald Gordon W
Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia.
Cancer genetics and cytogenetics 2006;167(2):177-81.
2006: Steensma D P; McClure R F; Karp J E; Tefferi A; Lasho T L; Powell H L; DeWald G W; Kaufmann S H
JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(6):971-8.
2006: Dingli David; Schwager Susan M; Mesa Ruben A; Li Chin-Yang; Dewald Gordon W; Tefferi Ayalew
Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
Cancer 2006;106(9):1985-9.
2006: Stockero Kimberly J; Fink Stephanie R; Smoley Stephanie A; Paternoster Sarah F; Shanafelt Tait D; Call Timothy G; Zent Clive S; Van Dyke Daniel L; Kay Neil E; Dewald Gordon W
Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia.
Cancer genetics and cytogenetics 2006;166(2):152-6.
2006: Persons Diane L; Tubbs Raymond R; Cooley Linda D; Dewald Gordon W; Dowling Patricia K; Du Emma; Mascarello James T; Rao Kathleen W; Wilson Kathleen S; Wolff Daynna J; Habegger-Vance Gail
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists.
Archives of pathology & laboratory medicine 2006;130(3):325-31.
2006: Wiktor Anne E; Van Dyke Daniel L; Stupca Peggy J; Ketterling Rhett P; Thorland Erik C; Shearer Brandon M; Fink Stephanie R; Stockero Kimberly J; Majorowicz Jason R; Dewald Gordon W
Preclinical validation of fluorescence in situ hybridization assays for clinical practice.
Genetics in medicine : official journal of the American College of Medical Genetics 2006;8(1):16-23.
2005: McClure Rebecca F; Remstein Ellen D; Macon William R; Dewald Gordon W; Habermann Thomas M; Hoering Antje; Kurtin Paul J
Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
The American journal of surgical pathology 2005;29(12):1652-60.
2005: Dewald Gordon W; Therneau Terry; Larson Dirk; Lee You Kyoung; Fink Stephanie; Smoley Stephanie; Paternoster Sarah; Adeyinka Adewale; Ketterling Rhett; Van Dyke Daniel L; Fonseca Rafael; Kyle Robert
Relationship of patient survival and chromosome anomalies detected in metaphase and/or interphase cells at diagnosis of myeloma.
Blood 2005;106(10):3553-8.
2005: Tefferi Ayalew; Dingli David; Li Chin-Yang; Dewald Gordon W
Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
Cancer 2005;104(8):1656-60.
2005: Steensma David P; Dewald Gordon W; Lasho Terra L; Powell Heather L; McClure Rebecca F; Levine Ross L; Gilliland D Gary; Tefferi Ayalew
The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.
Blood 2005;106(4):1207-9.
2005: Dingli David; Grand Francis H; Mahaffey Victor; Spurbeck Jack; Ross Fiona M; Watmore Ann E; Reilly John T; Cross Nicholas C P; Dewald Gordon W; Tefferi Ayalew
Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia.
British journal of haematology 2005;130(2):229-32.
2005: Nowakowski G S; Dewald G W; Hoyer J D; Paternoster S F; Stockero K J; Fink S R; Smoley S A; Remstein E D; Phyliky R L; Call T G; Shanafelt T D; Kay N E; Zent C S
Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia.
British journal of haematology 2005;130(1):36-42.
2005: Fink Stephanie R; Paternoster Sarah F; Smoley Stephanie A; Flynn Heather C; Geyer Susan M; Shanafelt Tait D; Lee You Kyoung; Jelinek Diane F; Kay Neil E; Dewald Gordon W
Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia.
Leukemia research 2005;29(3):253-62.
2005: Yoong Yinlee; VanDeWalker Todd J; Carlson Richard O; Dewald Gordon W; Tefferi Ayalew
Clinical correlates of submicroscopic deletions involving the ABL-BCR translocation region in chronic myeloid leukemia.
European journal of haematology 2005;74(2):124-7.
2005: Elliott M A; Hanson C A; Dewald G W; Smoley S A; Lasho T L; Tefferi A
WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(2):313-7.
2004: Mahaffey Victor J; Spurbeck Jack L; Carlson Richard O; Dewald Gordon W
Hematologic malignancies, critical genes and representative pictures for 166 chromosome anomalies.
Leukemia research 2004;28(12):1351-6.
2004: Pardanani Animesh; Brockman Stephanie R; Paternoster Sarah F; Flynn Heather C; Ketterling Rhett P; Lasho Terra L; Ho Ching-Liang; Li Chin-Yang; Dewald Gordon W; Tefferi Ayalew
FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.
Blood 2004;104(10):3038-45.
2004: Greipp Patricia T; Dewald Gordon W; Tefferi Ayalew
Prevalence, breakpoint distribution, and clinical correlates of t(5;12).
Cancer genetics and cytogenetics 2004;153(2):170-2.
2004: Spurbeck Jack L; Adams Sara Anne; Stupca Peggy J; Dewald Gordon W
Primer on medical genomics. Part XI: Visualizing human chromosomes.
Mayo Clinic proceedings. Mayo Clinic 2004;79(1):58-75.
2004: Smoley Stephanie A; Brockman Stephanie R; Paternoster Sarah F; Meyer Reid G; Dewald Gordon W
A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia.
Cancer genetics and cytogenetics 2004;148(1):1-6.
2004: Remstein E D; Kurtin P J; Einerson R R; Paternoster S F; Dewald G W
Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(1):156-60.
2004: Dewald Gordon W; Brockman Stephanie R; Paternoster Sarah F
Molecular cytogenetic studies for hematological malignancies.
Cancer treatment and research 2004;121():69-112.
2003: Cherry Athena M; Brockman Stephanie R; Paternoster Sarah F; Hicks Gary A; Neuberg Donna; Higgins Rodney R; Bennett John M; Greenberg Peter L; Miller Kenneth; Tallman Martin S; Rowe Jacob; Dewald Gordon W
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study.
Leukemia research 2003;27(12):1085-90.
2003: Pardanani Animesh; Ketterling Rhett P; Brockman Stephanie R; Flynn Heather C; Paternoster Sarah F; Shearer Brandon M; Reeder Terra L; Li Chin-Yang; Cross Nicholas C P; Cools Jan; Gilliland D Gary; Dewald Gordon W; Tefferi Ayalew
CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy.
Blood 2003;102(9):3093-6.
2003: Adeyinka Adewale; Dewald Gordon W
Cytogenetics of chronic myeloproliferative disorders and related myelodysplastic syndromes.
Hematology/oncology clinics of North America 2003;17(5):1129-49.
2003: Fonseca Rafael; Debes-Marun Carina S; Picken Elisa B; Dewald Gordon W; Bryant Sandra C; Winkler Jerry M; Blood Emily; Oken Martin M; Santana-Dávila Rafael; González-Paz Natalia; Kyle Robert A; Gertz Morie A; Dispenzieri Angela; Lacy Martha Q; Greipp Philip R
The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.
Blood 2003;102(7):2562-7.
2003: Mascarello James T; Cooley Linda D; Davison Keri; Dewald Gordon W; Brothman Arthur R; Herrman Marille; Park Jonathan P; Persons Diane L; Rao Kathleen W; Schneider Nancy R; Vance Gail H;
Problems with ISCN FISH Nomenclature make it not practical for use in clinical test reports or cytogenetic databases [corrected].
Genetics in medicine : official journal of the American College of Medical Genetics 2003;5(5):370-7.
2003: Brockman Stephanie R; Paternoster Sarah F; Ketterling Rhett P; Dewald Gordon W
New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia.
Cancer genetics and cytogenetics 2003;145(2):144-51.
2003: Fonseca Rafael; Blood Emily; Rue Montserrat; Harrington David; Oken Martin M; Kyle Robert A; Dewald Gordon W; Van Ness Brian; Van Wier Scott A; Henderson Kimberly J; Bailey Richard J; Greipp Philip R
Clinical and biologic implications of recurrent genomic aberrations in myeloma.
Blood 2003;101(11):4569-75.
2003: Dewald Gordon W; Brockman Stephanie R; Paternoster Sarah F; Bone Nancy D; O'Fallon Judith R; Allmer Cristine; James Charles D; Jelinek Diane F; Tschumper Renee C; Hanson Curtis A; Pruthi Rajiv K; Witzig Thomas E; Call Timothy G; Kay Neil E
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
British journal of haematology 2003;121(2):287-95.
2003: Steensma David P; Dewald Gordon W; Hodnefield Janice M; Tefferi Ayalew; Hanson Curtis A
Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?
Leukemia research 2003;27(3):235-42.
2003: Debes-Marun C S; Dewald G W; Bryant S; Picken E; Santana-Dávila R; González-Paz N; Winkler J M; Kyle R A; Gertz M A; Witzig T E; Dispenzieri A; Lacy M Q; Rajkumar S V; Lust J A; Greipp P R; Fonseca R
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(2):427-36.
2002: Mascarello James T; Brothman Arthur R; Davison Keri; Dewald Gordon W; Herrman Marille; McCandless Danette; Park Jonathan P; Persons Diane L; Rao Kathleen W; Schneider Nancy R; Vance Gail H; Cooley Linda D;
Proficiency testing for laboratories performing fluorescence in situ hybridization with chromosome-specific DNA probes.
Archives of pathology & laboratory medicine 2002;126(12):1458-62.
2002: Dewald Gordon W
Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma.
International journal of hematology 2002;76 Suppl 2():65-74.
2002: Tefferi Ayalew; Wieben Eric D; Dewald Gordon W; Whiteman David A H; Bernard Matthew E; Spelsberg Thomas C
Primer on medical genomics part II: Background principles and methods in molecular genetics.
Mayo Clinic proceedings. Mayo Clinic 2002;77(8):785-808.
2002: Lorentz Cindy Pham; Wieben Eric D; Tefferi Ayale; Whiteman David A H; Dewald Gordon W
Primer on medical genomics part I: History of genetics and sequencing of the human genome.
Mayo Clinic proceedings. Mayo Clinic 2002;77(8):773-82.
2002: Fonseca Rafael; Bailey Richard J; Ahmann Gregory J; Rajkumar S Vincent; Hoyer James D; Lust John A; Kyle Robert A; Gertz Morie A; Greipp Philip R; Dewald Gordon W
Genomic abnormalities in monoclonal gammopathy of undetermined significance.
Blood 2002;100(4):1417-24.
2002: Remstein Ellen D; Kurtin Paul J; James C David; Wang Xiao-Yang; Meyer Reid G; Dewald Gordon W
Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways.
The American journal of pathology 2002;161(1):63-71.
2002: Paternoster Sarah F; Brockman Stephanie R; McClure Rebecca F; Remstein Ellen D; Kurtin Paul J; Dewald Gordon W
A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization.
The American journal of pathology 2002;160(6):1967-72.
2002: Kay N E; Bone N D; Tschumper R C; Howell K H; Geyer S M; Dewald G W; Hanson C A; Jelinek D F
B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(5):911-9.
2002: Tefferi Ayalew; Mesa Ruben A; Gray Leigh A; Steensma David P; Camoriano John K; Elliott Michelle A; Pardanani Animesh; Ansell Stephen M; Call Timothy G; Colon-Otero Gerardo; Schroeder Georgene; Hanson Curtis A; Dewald Gordon W; Kaufmann Scott H
Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia.
Blood 2002;99(10):3854-6.
2002: Fonseca Rafael; Blood Emily A; Oken Martin M; Kyle Robert A; Dewald Gordon W; Bailey Richard J; Van Wier Scott A; Henderson Kimberly J; Hoyer James D; Harrington David; Kay Neil E; Van Ness Brian; Greipp Philip R
Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.
Blood 2002;99(10):3735-41.
2002: Kumar S; Menke D M; Dewald G W; Colon-Otero G
Agnogenic myeloid metaplasia associated with Klinefelter syndrome: a case report.
Annals of hematology 2002;81(4):215-8.
2002: Elliott Michelle A; Letendre Louis; Hanson Curtis A; Tefferi Ayalew; Dewald Gordon W
The prognostic significance of trisomy 8 in patients with acute myeloid leukemia.
Leukemia & lymphoma 2002;43(3):583-6.
2002: Ketterling Rhett P; Wyatt William A; VanWier Scott A; Law Mark; Hodnefield Janice M; Hanson Curtis A; Dewald Gordon W
Primary myelodysplastic syndrome with normal cytogenetics: utility of 'FISH panel testing' and M-FISH.
Leukemia research 2002;26(3):235-40.
2002: Fonseca Rafael; Harrington David; Oken Martin M; Dewald Gordon W; Bailey Richard J; Van Wier Scott A; Henderson Kimberly J; Blood Emily A; Rajkumar S Vincent; Kay Neil E; Van Ness Brian; Greipp Philip R
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.
Cancer research 2002;62(3):715-20.
2001: Jelinek D F; Tschumper R C; Geyer S M; Bone N D; Dewald G W; Hanson C A; Stenson M J; Witzig T E; Tefferi A; Kay N E
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
British journal of haematology 2001;115(4):854-61.
2001: Tefferi A; Meyer R G; Wyatt W A; Dewald G W
Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia.
British journal of haematology 2001;115(2):316-9.
2001: Fonseca R; Oken M M; Harrington D; Bailey R J; Van Wier S A; Henderson K J; Kay N E; Van Ness B; Greipp P R; Dewald G W
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(6):981-6.
2001: Tefferi A; Mesa R A; Schroeder G; Hanson C A; Li C Y; Dewald G W
Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia.
British journal of haematology 2001;113(3):763-71.
2001: Elliott M A; Dewald G W; Tefferi A; Hanson C A
Chronic neutrophilic leukemia (CNL): a clinical, pathologic and cytogenetic study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(1):35-40.
2000: Fonseca R; Rajkumar S V; Ahmann G J; Jalal S M; Hoyer J D; Gertz M A; Kyle R A; Greipp P R; Dewald G W
Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis.
Leukemia & lymphoma 2000;39(3-4):391-5.
2000: Remstein E D; Kurtin P J; Buño I; Bailey R J; Proffitt J; Wyatt W A; Hanson C A; Dewald G W
Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma.
British journal of haematology 2000;110(4):856-62.
2000: Hoyer J D; Hanson C A; Fonseca R; Greipp P R; Dewald G W; Kurtin P J
The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
American journal of clinical pathology 2000;113(6):831-7.
2000: Dewald G W; Stupca P
154 chromosome anomalies in hematologic malignancies.
Leukemia research 2000;24(6):487-9.
1999: Dewald G W; Wyatt W A; Silver R T
Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy.
Leukemia & lymphoma 1999;34(5-6):481-91.
1999: McClure R F; Dewald G W; Hoyer J D; Hanson C A
Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course.
British journal of haematology 1999;106(2):445-54.
1999: Park J P; Brothman A R; Butler M G; Cooley L D; Dewald G W; Lundquist K F; Palmer C G; Patil S R; Rao K W; Saikevych I A; Schneider N R; Vance G H
Extensive analysis of mosaicism in a case of Turner syndrome: the experience of 287 cytogenetic laboratories. College of American Pathologists/American College of Medical Genetics Cytogenetics Resource Committee.
Archives of pathology & laboratory medicine 1999;123(5):381-5.
1998: Fonseca R; Ahmann G J; Jalal S M; Dewald G W; Larson D R; Therneau T M; Gertz M A; Kyle R A; Greipp P R
Chromosomal abnormalities in systemic amyloidosis.
British journal of haematology 1998;103(3):704-10.
1998: Buño I; Wyatt W A; Zinsmeister A R; Dietz-Band J; Silver R T; Dewald G W
A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia.
Blood 1998;92(7):2315-21.
1998: Juneau A L; Kaehler M; Christensen E R; Schad C R; Zinsmeister A R; Lust J; Hanson C; Dewald G W
Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders.
Cancer genetics and cytogenetics 1998;103(2):117-23.
1998: Dewald G W; Wyatt W A; Juneau A L; Carlson R O; Zinsmeister A R; Jalal S M; Spurbeck J L; Silver R T
Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia.
Blood 1998;91(9):3357-65.
1998: Goldberg S L; Noel P; Klumpp T R; Dewald G W
The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
American journal of clinical oncology 1998;21(1):42-7.
1998: Jalal S M; Law M E; Carlson R O; Dewald G W
Prenatal detection of aneuploidy by directly labeled multicolored probes and interphase fluorescence in situ hybridization.
Mayo Clinic proceedings. Mayo Clinic 1998;73(2):132-7.
1998: Ahmann G J; Jalal S M; Juneau A L; Christensen E R; Hanson C A; Dewald G W; Greipp P R
A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies.
Cancer genetics and cytogenetics 1998;101(1):7-11.
1998: Cohen P L; Hoyer J D; Kurtin P J; Dewald G W; Hanson C A
Acute myeloid leukemia with minimal differentiation. A multiple parameter study.
American journal of clinical pathology 1998;109(1):32-8.
1997: Kuffel D G; Lindor N M; Litzow M R; Zinsmeister A R; Dewald G W
Mitomycin C chromosome stress test to identify hypersensitivity to bifunctional alkylating agents in patients with Fanconi anemia or aplastic anemia.
Mayo Clinic proceedings. Mayo Clinic 1997;72(6):579-80.
1997: Tefferi A; Litzow M R; Noel P; Dewald G W
Chronic granulocytic leukemia: recent information on pathogenesis, diagnosis, and disease monitoring.
Mayo Clinic proceedings. Mayo Clinic 1997;72(5):445-52.
1997: Dewald G W; Brothman A R; Butler M G; Cooley L D; Patil S R; Saikevych I A; Schneider N R
Pilot studies for proficiency testing using fluorescence in situ hybridization with chromosome-specific DNA probes: a College of American Pathologists/American College of Medical Genetics Program.
Archives of pathology & laboratory medicine 1997;121(4):359-67.
1997: Dewald G W; Juneau A L; Schad C R; Tefferi A
Cytogenetic and molecular genetic methods for diagnosis and treatment response in chronic granulocytic leukemia.
Cancer genetics and cytogenetics 1997;94(1):59-66.
1996: Schad C R; Kuffel D G; Wyatt W A; Zinsmeister A R; Jenkins R B; Dewald G W; Jalal S M
Application of fluorescent in situ hybridization with X and Y chromosome specific probes to buccal smear analysis.
American journal of medical genetics 1996;66(2):187-92.
1996: Rhoton-Vlasak A; Lu P Y; Barud K M; Dewald G W; Hammitt D G
Efficacy of calcium ionophore A23187 oocyte activation for generating parthenotes for human embryo research.
Journal of assisted reproduction and genetics 1996;13(10):793-6.
1996: Dewald G W; Stallard R; Bader P I; Chen K; Zenger-Hain J; Harris C J; Higgins R; Hirsch B; Hsu W T; Johnson E; Kubic V; Kurczynski T W; Malone J M; McCorquodale D J; Meilinger K; Meisner L F; Moore J W; Schwartz S; Siembieda S; Storto P D; Vance G; Van Tuinen P; Wiktor A; Yung J F
Toward quality assurance for metaphase FISH: a multicenter experience.
American journal of medical genetics 1996;65(3):190-6.
1996: Johnson T M; Kuffel D G; Dewald G W
Detection of hyperdiploid malignant cells in pleural effusions with chromosome-specific probes and fluorescence in situ hybridization.
Mayo Clinic proceedings. Mayo Clinic 1996;71(7):643-8.
1996: Lindor N M; Devries E M; Michels V V; Schad C R; Jalal S M; Donovan K M; Smithson W A; Kvols L K; Thibodeau S N; Dewald G W
Rothmund-Thomson syndrome in siblings: evidence for acquired in vivo mosaicism.
Clinical genetics 1996;49(3):124-9.
1995: Crifasi P A; Michels V V; Driscoll D J; Jalal S M; Dewald G W
DNA fluorescent probes for diagnosis of velocardiofacial and related syndromes.
Mayo Clinic proceedings. Mayo Clinic 1995;70(12):1148-53.
1995: Lindor N M; Karnes P S; Michels V V; Dewald G W; Goerss J; Jalal S; Jenkins R B; Vockley G; Thibodeau S N
Uniparental disomy in congenital disorders: a prospective study.
American journal of medical genetics 1995;58(2):143-6.
1995: Tefferi A; Schad C R; Pruthi R K; Ahmann G J; Spurbeck J L; Dewald G W
Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia.
Cancer genetics and cytogenetics 1995;83(1):61-4.
1995: Dewald G W; Wright P I
Chromosome abnormalities in the myeloproliferative disorders.
Seminars in oncology 1995;22(4):341-54.
1995: Windebank A J; Schenone A; Dewald G W
Hereditary neuropathy with liability to pressure palsies and inherited brachial plexus neuropathy--two genetically distinct disorders.
Mayo Clinic proceedings. Mayo Clinic 1995;70(8):743-6.
1994: Schad C R; Hanson C A; Paietta E; Casper J; Jalal S M; Dewald G W
Efficacy of fluorescence in situ hybridization for detecting PML/RARA gene fusion in treated and untreated acute promyelocytic leukemia.
Mayo Clinic proceedings. Mayo Clinic 1994;69(11):1047-53.
1994: Jalal S M; Law M E; Dewald G W; Sekhor G S; Van Dyke D L
Detection of 46,XX male by Y-specific whole chromosome paint probe.
American journal of medical genetics 1994;52(2):239-41.
1993: Dewald G W; Schad C R; Christensen E R; Tiede A L; Zinsmeister A R; Spurbeck J L; Thibodeau S N; Jalal S M
The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL.
Cancer genetics and cytogenetics 1993;71(1):7-14.
1993: Dewald G W; Schad C R; Christensen E R; Law M E; Zinsmeister A R; Stalboerger P G; Jalal S M; Ash R C; Jenkins R B
Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantation.
Bone marrow transplantation 1993;12(2):149-54.
1993: Dewald G W; Schad C R; Lilla V C; Jalal S M
Frequency and photographs of HGM11 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms.
Cancer genetics and cytogenetics 1993;68(1):60-9.
1993: Jalal S M; Law M E; Dewald G W
Inverted duplication involving alpha satellite DNA resulting in a C-negative-band in the qh region of chromosome 16.
American journal of medical genetics 1993;46(3):351-2.
1993: Jalal S M; Law M E; Christensen E R; Spurbeck J L; Dewald G W
Method for sequential staining of GTL-banded metaphases with fluorescent-labeled chromosome-specific paint probes.
American journal of medical genetics 1993;46(1):98-103.
1992: Dewald G W; Buckley D D; Spurbeck J L; Jalal S M
Cytogenetic guidelines for fragile X studies tested in routine practice.
American journal of medical genetics 1992;44(6):816-21.
1992: Lindor N M; Michels V V; Hoppe D A; Driscoll D J; Leavitt J A; Dewald G W
Xp22.3 microdeletion syndrome with microphthalmia, sclerocornea, linear skin defects, and congenital heart defects.
American journal of medical genetics 1992;44(1):61-5.
1992: Moertel C A; Stupca P J; Dewald G W
Pseudomosaicism, true mosaicism, and maternal cell contamination in amniotic fluid processed with in situ culture and robotic harvesting.
Prenatal diagnosis 1992;12(8):671-83.
1992: Lindor N M; Ney J A; Gaffey T A; Jenkins R B; Thibodeau S N; Dewald G W
A genetic review of complete and partial hydatidiform moles and nonmolar triploidy.
Mayo Clinic proceedings. Mayo Clinic 1992;67(8):791-9.
1992: Kraker W J; Borell T J; Schad C R; Pennington M J; Karnes P S; Dewald G W; Jenkins R B
Fluorescent in situ hybridization: use of whole chromosome paint probes to identify unbalanced chromosome translocations.
Mayo Clinic proceedings. Mayo Clinic 1992;67(7):658-62.
1991: Kuffel D G; Schultz C G; Ash R C; Dewald G W
Normal cytogenetic values for bone marrow based on studies of bone marrow transplant donors.
Cancer genetics and cytogenetics 1991;55(1):39-48.
1991: Diez-Martin J L; Graham D L; Petitt R M; Dewald G W
Chromosome studies in 104 patients with polycythemia vera.
Mayo Clinic proceedings. Mayo Clinic 1991;66(3):287-99.
1990: Inwards D J; Habermann T M; Banks P M; Colgan J P; Dewald G W
Cytogenetic findings in 21 cases of peripheral T-cell lymphoma.
American journal of hematology 1990;35(2):88-95.
1990: Jenkins R B; Hay I D; Herath J F; Schultz C G; Spurbeck J L; Grant C S; Goellner J R; Dewald G W
Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma.
Cancer 1990;66(6):1213-20.
1990: Dewald G W; Diez-Martin J L; Steffen S L; Jenkins R B; Stupca P J; Burgert E O
Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome.
American journal of medical genetics. Supplement 1990;7():247-50.
1989: Dewald G W; Brecher M; Travis L B; Stupca P J
Twenty-six patients with hematologic disorders and X chromosome abnormalities. Frequent idic(X)(q13) chromosomes and Xq13 anomalies associated with pathologic ringed sideroblasts.
Cancer genetics and cytogenetics 1989;42(2):173-85.
1989: Jenkins R B; Kimmel D W; Moertel C A; Schultz C G; Scheithauer B W; Kelly P J; Dewald G W
A cytogenetic study of 53 human gliomas.
Cancer genetics and cytogenetics 1989;39(2):253-79.
1989: Schwartz H S; Jenkins R B; Dahl R J; Dewald G W
Cytogenetic analyses on giant-cell tumors of bone.
Clinical orthopaedics and related research 1989;(240):250-60.
1989: De Fusco P A; Frytak S; Dahl R J; Weiland L H; Unni K K; Dewald G W
Cytogenetic studies in 11 patients with small cell carcinoma of the lung.
Mayo Clinic proceedings. Mayo Clinic 1989;64(2):168-76.
1988: Johnson D D; Dobyns W B; Gordon H; Dewald G W
Familial pericentric and paracentric inversions of chromosome 1.
Human genetics 1988;79(4):315-20.
1988: Spurbeck J L; Carlson R O; Allen J E; Dewald G W
Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques.
Cancer genetics and cytogenetics 1988;32(1):59-66.
1988: Diez-Martin J L; Dewald G W; Pierre R V
Possible cytogenetic distinction between lymphoid and myeloid blast crisis in chronic granulocytic leukemia.
American journal of hematology 1988;27(3):194-203.
1987: Dewald G W
Theoretical proportion of trisomy 21 originating in meiosis I and II.
American journal of medical genetics 1987;28(2):513-5.
1987: Dewald G W; Dahl R J; Spurbeck J L; Carney J A; Gordon H
Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas.
Mayo Clinic proceedings. Mayo Clinic 1987;62(7):558-67.
1986: Dewald G W; Noonan K J; Spurbeck J L; Johnson D D
T-lymphocytes with 7;14 translocations: frequency of occurrence, breakpoints, and clinical and biological significance.
American journal of human genetics 1986;38(4):520-32.
1986: Morrison-DeLap S J; Kuffel D G; Dewald G W; Letendre L
Unbalanced 1;7 translocation and therapy-induced hematologic disorders: a possible relationship.
American journal of hematology 1986;21(1):39-47.
1985: Dewald G W; Noel P; Dahl R J; Spurbeck J L
Chromosome abnormalities in malignant hematologic disorders.
Mayo Clinic proceedings. Mayo Clinic 1985;60(10):675-89.
1985: Dobyns W B; Dewald G W; Carlson R O; Mair D D; Michels V V
Deficiency of chromosome 8p21.1----8pter: case report and review of the literature.
American journal of medical genetics 1985;22(1):125-34.
1983: Dewald G W; Morrison-DeLap S J; Schuchard K A; Spurbeck J L; Pierre R V
A possible specific chromosome marker for monocytic leukemia: three more patients with t(9;11)(p22;q24) and another with t(11;17)(q24;q21), each with acute monoblastic leukemia.
Cancer genetics and cytogenetics 1983;8(3):203-12.

Sign-in to see more